These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11124651

  • 1. Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients.
    van Noord JA, Smeets JJ, Creemers JP, Greefhorst LP, Dewberry H, Cornelissen PJ.
    Respiration; 2000; 67(6):672-8. PubMed ID: 11124651
    [Abstract] [Full Text] [Related]

  • 2. Fenoterol delivery by Respimat soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patients.
    Vincken W, Dewberry H, Moonen D.
    J Asthma; 2003 Sep; 40(6):721-30. PubMed ID: 14580004
    [Abstract] [Full Text] [Related]

  • 3. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G, Magnussen H, Bergmann K, Juergens UR, de Mey C, Freund E, Hinzmann R, Beckers B.
    Respiration; 2000 Sep; 67(3):306-14. PubMed ID: 10867600
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk H.
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP, Greefhorst LP, Smeets JJ, Wald FD, Cornelissen PJ.
    Respiration; 1997 Jan; 64(4):273-80. PubMed ID: 9257362
    [Abstract] [Full Text] [Related]

  • 9. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J, Böhning W, Schmidt P, Freund E.
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [Abstract] [Full Text] [Related]

  • 10. Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.
    Iacono P, Velicitat P, Guemas E, Leclerc V, Thébault JJ.
    Respir Med; 2000 May; 94(5):490-5. PubMed ID: 10868713
    [Abstract] [Full Text] [Related]

  • 11. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
    Pavia D, Moonen D.
    J Aerosol Med; 1999 May; 12 Suppl 1():S33-9. PubMed ID: 10623340
    [Abstract] [Full Text] [Related]

  • 12. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F, Hodder R, Bateman ED.
    Drugs; 2004 May; 64(15):1671-82. PubMed ID: 15257628
    [Abstract] [Full Text] [Related]

  • 13. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies.
    Koehler D, Pavia D, Dewberry H, Hodder R.
    Respiration; 2004 May; 71(5):469-76. PubMed ID: 15467324
    [Abstract] [Full Text] [Related]

  • 14. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P, Hederer B, Austen G, Dewberry H, Meyer T.
    Int J Chron Obstruct Pulmon Dis; 2008 May; 3(4):763-70. PubMed ID: 19281091
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC, Combivent Respimat Inhaler Study Group.
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G, Hofbauer P, Cannizzaro G, Iacono P, Wald F.
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [Abstract] [Full Text] [Related]

  • 20. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
    Dubakiene R, Nargela R, Sakalauskas R, Vahteristo M, Silvasti M, Lähelmä S.
    Respiration; 2006 May; 73(4):441-8. PubMed ID: 16432294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.